Fstl1, a glycoprotein highly expressed in glioblastoma, competitively binds DIP2A to block DIP2A nuclear translocation, so as to hinder DIP2A from binding the HDAC2–DMAP1 complex. This evidence concerns the gene FSTL1 and glioblastoma.